✦ LIBER ✦

Enoxaparin and glycoprotein IIb/IIIa inhibition in non–ST-elevation acute coronary syndrome: Insights from the INTERACT trial

✍ Scribed by Shaun Goodman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous glycoprotein IIb/IIIa inhibi

✍ Derek P Chew; Marco Roffi; Eric J Topol 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Dynamic prognostication in non-ST–elevat

✍ Wei-Ching Chang; Eric Boersma; Christopher B Granger; Robert A Harrington; Rober 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Platelet glycoprotein IIb/IIIa inhibitor

✍ M. Roffi; D.P. Chew; D. Mukherjee 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Glycoprotein IIb-IIIa Inhibitors in the

✍ Cedric W. Lefebvre; James W. Hoekstra; Marc Bonaca; Robert Giugliano 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Enoxaparin versus tinzaparin in non-ST–s

✍ Lampros K Michalis; Christos S Katsouras; Nikos Papamichael; Kostas Adamides; Ka 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Trials of glycoprotein IIb-IIIa inhibito

✍ W. W. Parmley 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB